K. Masuda

发表

The efficacy of combined treatment with recombinant human tumor necrosis factor-alpha and 5-fluorouracil is dependent on the development of capillaries in tumor.

T. Nakamura, F. Nishigaki, T. Manda, 1990, European journal of cancer.

A new antitumor antibiotic, FK973: its metabolism in the blood and the antitumor effects of its metabolites on experimental models.

T. Nakamura, S. Takagaki, H. Noguchi, 1989, Japanese journal of pharmacology.

Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.

T. Nakamura, T. Oku, F. Nishigaki, 1988, Cancer research.

A new antitumor antibiotic, FR-900482: V. Interstrand DNA-DNA cross-links in L1210 cells.

T. Nakamura, M. Kohsaka, H. Terano, 1988, The Journal of antibiotics.

Interstrand DNA-DNA and DNA-protein cross-links by a new antitumor antibiotic, FK973, in L1210 cells.

T. Nakamura, J. Mori, T. Mizota, 1988, Cancer research.

Specific metabolic activation of FK973, a new antitumor antibiotic, in L1210 leukemia cells.

T. Nakamura, K. Shimomura, K. Masuda, 1990, Japanese journal of pharmacology.

Effect of FK973, a new antitumor antibiotic, on the cell cycle of L1210 cells in vitro.

T. Nakamura, T. Oku, J. Mori, 1989, Japanese journal of pharmacology.

In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative

A. Tsuji, S. Goto, K. Masuda, 1989, Antimicrobial Agents and Chemotherapy.

Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.

T. Nakamura, I. Kawamura, F. Nishigaki, 1989, Arzneimittel-Forschung.